Management of side effects of endocrine treatment for prostate cancer
Kamoto, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 299-303
2002
ISSN/ISBN: 0047-1852 PMID: 12599589 Document Number: 549627
Document emailed within 1 workday
Related Documents
Neri, B.; Bartalucci, S.; Pieri, A.; Gemelli, M.T.; Rizzo, M.; Bartoletti, R.; Trippitelli, A.; Paoletti, M.C. 1989: Complete androgen blockade as treatment for advanced prostate cancer: clinical response and side-effects Anticancer Research 9(1): 13-16Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Ayers, K.M.; Colquhoun, A.N. 2000: Leukaemia in children. Part II--Dental care of the leukaemic child, including management of oral side effects of cancer treatment New Zealand Dental Journal 96(426): 141-146
Boccardo, F.; Pace, M. 1993: Endocrine treatment of prostate cancer: standard treatment and new perspectives In Vivo 7(5): 423-424
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Noguchi, S.; Kubota, Y.; Shuin, T.; Masuda, M.; Misaki, H.; Yao, M.; Kondoh, K.; Sakuramoto, T.; Hosaka, M. 1994: M-VAC chemotherapy for advanced urothelial cancer--side effects and their management Hinyokika Kiyo. Acta Urologica Japonica 40(8): 677-682
Arai, G.; Okada, H. 2016: Androgen deprivation therapy for prostate cancer: adverse effects and their management Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 605-609
Chen, W.J.Y.; Krul-Poel, Y.H.M.; Roth, C.; Labots, M.; van den Eertwegh, A.J.M.; Dreijerink, K.M.A. 2019: Endocrine side effects of checkpoint inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Di Lauro, A. 1977: Side-effects of lithium salt therapy on some endocrine glands Acta Neurologica 32(4): 481-489
Anscher, M.S. 1999: More about prostate cancer--expectant management versus treatment North Carolina Medical Journal 60(6): 313-314
Falcone, T.; Falutz, G.; Tolis, G. 1982: LH-RH-endocrine manipulation in cancer of the prostate Biomedicine and PharmacoTherapy 36(8-9): 344-348
Wilding, G. 1995: Endocrine control of prostate cancer Cancer Surveys 23: 43-62
O'Rourke, M.E. 2008: Expectant management as a treatment for early-stage prostate cancer Oncology 22(2 Suppl Nurse Ed): 36-38
Kato, H.; Inoue, S.; Takahashi, K.; Yamanaka, A.; Okada, Y. 1987: UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1866-1870
Usami, M. 1998: Endocrine therapy for prostate cancer in the future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(6): 817-822
Ziegler, R.; Uhl, K.; Minne, H.; Russmann, D.; Döring, B. 1980: On the question of endocrine side effects in patients on medication for renal calcium stone disease Der Urologe. Ausg. a 19(4): 226-230
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Imaida, K.; Shirai, T. 2000: Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58(12): 2527-2532